দেশ: যুক্তরাজ্য
ভাষা: ইংরেজি
সূত্র: MHRA (Medicines & Healthcare Products Regulatory Agency)
Aminoacridine hydrochloride; Lidocaine hydrochloride
Dendron Ltd
Aminoacridine hydrochloride; Lidocaine hydrochloride
500microgram/1gram ; 6.6mg/1gram
Oromucosal gel
Oromucosal; Gingival
No Controlled Drug Status
Valid as a prescribable product
BNF: ; GTIN: 5016379296505
PLEASE READ ALL OF THIS LEAFLET CAREFULLY BEFORE USING THIS PRODUCT. Keep this leaflet. You may need to read it again. Ask your doctor, dentist or pharmacist if you need more information or advice. You must contact a doctor or dentist if your symptoms worsen or do not improve. If any of the side effects gets serious, or if you notice any side effect not listed in this leaflet, please tell your doctor, dentist or pharmacist. IN THIS LEAFLET: 1. What Iglü Rapid Relief Gel is and what it is used for 2. Before you use Iglü Rapid Relief Gel 3. How to use Iglü Rapid Relief Gel 4. Possible side effects 5. How to store Iglü Rapid Relief Gel 6. Further information 1. WHAT IGLÜ RAPID RELIEF GEL IS AND WHAT IT IS USED FOR • Iglü Rapid Relief Gel is a treatment for fast, effective relief of pain from common mouth ulcers, sore gums and denture rubbing. • The product, which at first looks like a pale yellow paste, forms a smooth, flexible and adhesive protective gel coating when it becomes wet on contact with saliva inside the mouth. • Iglü Rapid Relief Gel is suitable for use by ADULTS, THE ELDERLY AND CHILDREN OVER 7 YEARS OF AGE. • The product works in three ways: • by forming a gel coating to protect the sensitive and delicate area of the mouth lining as it heals, and • by the actions of its two ACTIVE INGREDIENTS, lidocaine hydrochloride and aminoacridine hydrochloride, which work by: • stopping pain (lidocaine hydrochloride is a local anaesthetic), and • preventing infection (aminoacridine hydrochloride is an antiseptic). 2. BEFORE YOU USE IGLÜ RAPID RELIEF GEL DO NOT USE Iglü Rapid Relief Gel if you are ALLERGIC (HYPERSENSITIVE) to lidocaine hydrochloride, aminoacridine hydrochloride or any of the other ingredients of Iglü Rapid Relief Gel listed in Section 6. TAKE SPECIAL CARE when using this product: • Apply it sparingly. • Keep the product away from your eyes. USING OTHER MEDICINES Iglü Rapid Relief Gel is not known to affect, or to be affected by, any other medicines. PREGNANCY AND BRE সম্পূর্ণ নথি পড়ুন
OBJECT 1 IGLU RAPID RELIEF GEL Summary of Product Characteristics Updated 06-May-2015 | Diomed Developments Limited 1. Name of the medicinal product IGLÜ ® RAPID RELIEF GEL 2. Qualitative and quantitative composition Lidocaine Hydrochloride 0.66% w/w; Aminoacridine Hydrochloride 0.05% w/w. For full list of excipients, see section List of Excipients. 3. Pharmaceutical form Soft, pale yellow, slightly opalescent oromucosal gel. 4. Clinical particulars 4.1 Therapeutic indications For fast, effective relief from the pain of common mouth ulcers, soreness of gums and denture rubbing. 4.2 Posology and method of administration For use in the mouth. For adults, the elderly and children over 7 years old. Apply sparingly, directly to the affected area(s) with a clean finger tip or a cotton wool bud. Re-apply as necessary the aim being to keep the affected area(s) protected with a thin layer of gel. As a guide, each application should normally last for an hour or more, although eating and/or drinking may necessitate more frequent re-application. In some cases, applications may remain in place for several hours. 4.3 Contraindications Do not use in cases of known sensitivity to lidocaine hydrochloride (or other local anaesthetics of the amide-type), aminoacridine hydrochloride or any of the other ingredients. 4.4 Special warnings and precautions for use Keep the product away from the eyes. In case of accidental contact, wash eye immediately with water: keep rinsing for 10 to 15 minutes, holding the eyelids well apart and avoid getting the rinse liquid into the other eye. Consult a doctor if irritation persists. If symptoms persist consult your doctor or dentist. 4.5 Interaction with other medicinal products and other forms of interaction None known. 4.6 Pregnancy and lactation Animal studies are insufficient with respect to effects on pregnancy and lactation (see section Preclinical Safety Data). The potential risk for humans is unknown. Caution should therefore be exercised before recommending this treatment for use duri সম্পূর্ণ নথি পড়ুন